"For over 40 years, Los Alamitos Cardiovascular has provided quality heart health care for Los Angeles and Orange County residents. Our cardiologists provide expertise in several sub-specialties - ensuring that you receive the best possible care. Our facility is designed to be one-stop office for state-of-the-art diagnostic testing and therapeutic services. Our out-patient services include electrocardiography, nuclear stress testing, echo stress testing, peripheral arterial testing, venous ultrasound, varicose veins and spider veins treatment, and much more. We are conveniently located in Los Alamitos, just minutes away from Orange County and Los Angeles. Give us a call and schedule with us today!"

During the past decade, Los Alamitos Cardiovascular conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Los Alamitos Cardiovascular" #1 sponsor was "Amgen" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "CVRx, Inc." with 1 trials sponsored and "Eko Devices, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Los Alamitos Cardiovascular" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Los Alamitos Cardiovascular" are "Heart Failure" (2 trials), "ASCVD" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials) and "Left Ventricular Dysfunction" (1 trials). Many other conditions were trialed in "Los Alamitos Cardiovascular" in a lesser frequency.

Most popular intervention types in "Los Alamitos Cardiovascular" are "Device" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aptar Pharma Nasal Spray Bidose System" (1 trials), "BAROSTIM NEO® System" (1 trials), "Etripamil NS 70 mg" (1 trials), "Medical Management" (1 trials) and "Methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Los Alamitos Cardiovascular" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Los Alamitos Cardiovascular". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Los Alamitos Cardiovascular, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Los Alamitos Cardiovascular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".